Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.

Abstract

The information provided by the flow cytometric immunophenotyping of hematological malignancies is of great clinical utility, with a major challenge for the near future being the standardization of technical procedures, data interpretation, and reporting.